Thus, by promoting MDM2 expression and suppressing TP53, CHD1L enhances tumor cell survival and proliferation while disabling key apoptotic checkpoints, further supporting its role as a central suppressor of programmed cell death in cancer. Here, CHD1L is linked to neoplasm.